BFRI
Biofrontera, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website biofrontera-us.com
- Employees(FY) 81
- ISIN US09077D2099
Performance
-32.28%
1W
-41.16%
1M
+42.76%
3M
-71.77%
6M
-61.37%
YTD
-87.56%
1Y
Profile
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Technical Analysis of BFRI 2024-05-10
Overview:
In analyzing the technical indicators for BFRI over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming trading days.
Trend An...
Recent News & Updates
- 2024-05-15 09:53
- 2024-05-15 04:45
- 2024-05-05 22:30
- 2024-05-02 20:50
- 2024-03-26 04:30
- 2024-03-18 21:22
- 2024-03-15 09:52
- 2024-03-15 08:25
- 2024-03-15 08:25
- 2024-03-15 06:10
- 2024-03-07 20:00
- 2024-02-22 19:40
- 2024-02-19 19:10
- 2024-02-19 19:05
- 2024-02-05 04:15
- 2024-02-01 19:07
Why Is Biofrontera (BFRI) Stock Down Today?(Investorplace)
- 2024-01-11 03:15
- 2023-11-21 20:55
- 2023-11-10 23:05
- 2023-11-09 04:10
- 2023-11-08 23:00
- 2023-11-02 20:30
- 2023-10-30 20:01
- 2023-10-09 21:00
- 2023-10-04 21:00
- 2023-10-03 20:30
- 2023-08-28 20:00
- 2023-08-27 20:00
- 2023-08-10 20:25
- 2023-08-10 19:00
Page 1 of 4
previousnext